APA (7th ed.) Citation

M, D., JS, D., J, M., M, K., N, E., RI, W., . . . H, W. (2011). Results from a single institution phase II trial of concurrent docetaxel/carboplatin/radiotherapy followed by surgical resection and consolidation docetaxel/carboplatin in stage III non-small-cell lung cancer. Clinical lung cancer, 12(5), 280. https://doi.org/10.1016/j.cllc.2011.06.003

Chicago Style (17th ed.) Citation

M, Das, et al. "Results from a Single Institution Phase II Trial of Concurrent Docetaxel/carboplatin/radiotherapy Followed by Surgical Resection and Consolidation Docetaxel/carboplatin in Stage III Non-small-cell Lung Cancer." Clinical Lung Cancer 12, no. 5 (2011): 280. https://doi.org/10.1016/j.cllc.2011.06.003.

MLA (9th ed.) Citation

M, Das, et al. "Results from a Single Institution Phase II Trial of Concurrent Docetaxel/carboplatin/radiotherapy Followed by Surgical Resection and Consolidation Docetaxel/carboplatin in Stage III Non-small-cell Lung Cancer." Clinical Lung Cancer, vol. 12, no. 5, 2011, p. 280, https://doi.org/10.1016/j.cllc.2011.06.003.